Literature DB >> 26731486

Cryptococcal iridociliary granuloma.

Yahya A Alzahrani1, Hassan A Aziz1, Nabin K Shrestha2, Charles V Biscotti3, Arun D Singh4.   

Abstract

Cryptococcal intraocular infection is a rare disease and is usually associated with generalized systemic disease in immunocompromised patients. The diagnosis may be difficult because of the rarity of this disease and its similarities to other uveitic entities. We describe a case of culture-positive cryptococcal iridociliary granuloma diagnosed by anterior chamber tap and fine-needle aspiration biopsy in a 60-year-old immunocompetent woman with acute granulomatous uveitis. She was treated successfully with systemic amphotericin B and fluconazole and intravitreal amphotericin B, with improvement in the inflammation and visual acuity and regression of the iridociliary granuloma. We review previously reported cases of intraocular cryptococcal infection. Cryptococcal iridociliary granuloma should be considered in the differential diagnosis of an atypical iridociliary mass associated with acute uveitis.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  cryptococcus; granuloma; inflammmation; irido ciliary; uvea

Mesh:

Year:  2015        PMID: 26731486     DOI: 10.1016/j.survophthal.2015.12.005

Source DB:  PubMed          Journal:  Surv Ophthalmol        ISSN: 0039-6257            Impact factor:   6.048


  2 in total

1.  Cryptococcus laurentii endogenous endophthalmitis post COVID-19 infection.

Authors:  Muthugaduru Jagadish Deepa; Chitta Megharaj; Santosh Patil; Padmaja Kumari Rani
Journal:  BMJ Case Rep       Date:  2022-05-11

2.  Involvement of the capsular GalXM-induced IL-17 cytokine in the control of Cryptococcus neoformans infection.

Authors:  Isabel Ferreira LaRocque-de-Freitas; Juliana Dutra B Rocha; Marise Pinheiro Nunes; Priscila Angelica V Oliveira; Danielle de Oliveira Nascimento; Leonardo Freire-de-Lima; Christina Maeda Takiya; Alexandre Morrot; Debora Decote-Ricardo; Jose Osvaldo Previato; George A DosReis; Lucia Mendonça-Previato; Celio Geraldo Freire-de-Lima
Journal:  Sci Rep       Date:  2018-11-06       Impact factor: 4.379

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.